Cardiac Implant Supply – Transcatheter Heart Valves

The contract involves the supply of FDA-approved transcatheter aortic and mitral heart valves to VA medical facilities, ensuring that veterans have access to critical cardiac interventions using approved medical devices. The procurement is categorized as a subcontract under NAICS code 339112, which pertains to surgical and medical instrument manufacturing, and is managed by the Department of Veterans Affairs through the 261-NETWORK Contract Office 21. The contract was posted on August 6, 2026, and is intended to support clinical care across VA healthcare centers, with performance occurring at various VA facility locations nationwide. The valves must meet all applicable FDA standards and be capable of integration into existing interventional cardiac procedures at VA hospitals. While specific delivery schedules, quantities, or pricing are not detailed in the provided data, the contract underscores the VA’s commitment to maintaining a reliable supply chain for high-risk, life-saving cardiovascular implants. No set-aside provisions or geographic restrictions are indicated, and the point of contact information is not provided, suggesting the contract may be administered internally or through existing VA procurement channels.